2 recruiting, 1 completed. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Recruiting 2, Completed 1 |
Follow Aplastic Anemia: new trials by email Literature Review of Aplastic Anemia trials Research Report on Aplastic Anemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation - Aplastic Anemia | Early Phase 1 | Recruiting | Zhejiang University | 30 | 2024-10-20 | 2024-10-09 |
| Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies Darzalex Faspro (Daratumumab and hyaluronidase-fihj), JH-DSA Semi-Quant Screen and Response Score - Hematologic Malignancy, Bone Marrow Transplant Rejection | Early Phase 1 | Recruiting | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 8 | 2024-09-19 | 2026-10-05 |
| TPO-Mimetic Use in Children for Hematopoietic Failure Romiplostim - Bone Marrow Failure Disorders, Aplastic Anemia | Early Phase 1 | Completed | Anjali Sharathkumar | 15 | 2020-08-18 | 2024-07-30 |
Anemia, Aplastic (3) · Myelodysplastic Syndromes (2) · Bone Marrow Failure Disorders (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Primary Myelofibrosis (1) · Thrombocytopenia (1)
Anemia (3) · Bone Marrow Diseases (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Bone Marrow Failure Disorders (2) · Blood Platelet Disorders (1) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Cytopenia (1) · Disease Attributes (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1)
daratumumab (1) · romiplostim (1)
Anjali Sharathkumar (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1) · Zhejiang University (1)
United States (2) · China (1)
Anjali A. Sharathkumar, MBBS, MD, MS (1) · Christian B Gocke, MD, PhD (1) · He Huang, MD (1)